Search clinical trials for: Partial Onset Seizures (POS)

Total 4642 results

Sunovion

Completed

Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic

Epilepsy

United States, Bulgaria, Czech Republic, Serbia, Ukraine
Pfizer

Completed

Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.

Epilepsy | Epilepsy, Generalized | Seizures | Epilepsies, Partial | Epilepsy, Complex Partial

United States
GlaxoSmithKline

Completed

Pediatric Epilepsy Trial in Subjects 1-24 Months

Epilepsy

United States, Estonia, Portugal, Slovakia, Netherlands, Hungary, Italy, Lithuania, Australia, France, Spain, Latvia, Lebanon, Turkey
Lundbeck LLC

Completed

Sabril Patient Registry

Infantile Spasms | Refractory Complex Partial Seizures in Adults
Lundbeck LLC

Completed

A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)

Adult Refractory Complex Partial Seizures

United States
University of Aarhus
Aarhus University Hospital

Completed

Stopping and Preventing Epileptic Seizures Using a Partial Rebreathing Mask (EpiCapno)

Epilepsy

Denmark
Eisai Limited

Terminated

A Study to Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures

Epilepsy

United Kingdom, Germany, Hungary, Switzerland, Italy, Netherlands, Poland
Eisai Inc.

Completed

Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures

Epilepsy

Greece, Italy, Spain, Sweden, Korea, Republic of, Germany, Australia, France, Switzerland, Slovakia, Poland, Taiwan, Hungary, Serbia, India, United Kingdom, Denmark, Russian Federation, South Africa, Montenegro
Eisai Inc.

Completed

4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures

Epilepsy

Belgium, France, United States, Czech Republic, Estonia, Latvia, Spain, United Kingdom, Lithuania, Germany, Australia, Finland, Netherlands, Sweden
Eisai Inc.

Completed

E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures

Epilepsy

United States
Maastricht University Medical Center
Epilepsiecentrum Kempenhaeghe

Completed

The Rolandic Epilepsy/ESES/Landau-Kleffner Syndrome and Correlation With Language Impairment Study (REL)

Rolandic Epilepsy | Landau-Kleffner Syndrome | Nocturnal Frontal Lobe Epilepsy | Electrical Status Epilepticus During Slow Wave Sleep

Netherlands
UCB Japan Co. Ltd.

Completed

An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures

Epilepsy | Partial Seizures

Japan
Pfizer

Completed

Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Seizure Disorder, Partial

Australia, Spain, Portugal, United Kingdom, Canada, Belgium, Germany, Poland, Netherlands, Austria
UCB Pharma

Completed

Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures

Epilepsies, Partial

United States
UCB Pharma

Completed

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Partial Seizures With or Without Secondary Generalization

Germany
UCB Pharma

Completed

SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Epilepsy
UCB Pharma

Completed

Conversion to Monotherapy Study With Keppra XR for Partial Seizures

Epilepsy

Poland, United States, Mexico, Russian Federation
UCB Pharma

Completed

Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures

Epilepsy

United States, Poland, Mexico, Russian Federation
Emory University
Baxter Healthcare Corporation

Terminated

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

Seizure Disorder | Epilepsy, Partial | Epilepsy, Cryptogenic | Autoimmune Diseases, Nervous System | Limbic Encephalitis

United States
Eisai Inc.

Completed

Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures

Partial Seizures

China
Eisai Inc.

Completed

Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug

Partial Seizures

Italy
Eisai Co., Ltd.
Eisai Limited

Completed

Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

Epilepsy

Latvia
Bial - Portela C S.A.

Completed

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures

Refractory Partial Epilepsy

Portugal
National Center for Complementary and Integrative...

Completed

Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures (FOS)

Epilepsy

United States
Eisai Inc.

Completed

A Study to Evaluate the Safety and Efficacy of Zonisamide an Antiepileptic Drug as Monotherapy or Adjunctive Therapy in Treatment of Adult Patients With Partial, Generalized or Combined Seizures.

Partial, Generalized and Combined Seizures

India
UCB Pharma

Completed

Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.

Epilepsy, Partial
Atlantic University
A.T. Still University of Health Sciences

Completed

Thermographic Examination of Skin Temperatures in Individuals With Focal Onset Epilepsy

Partial Epilepsy | Focal Onset Epilepsy

United States
Olive View-UCLA Education & Research Institute
Boston Scientific Corporation; Epilepsy Foundation

Completed

External Trigeminal Nerve Stimulation for Epilepsy

Epilepsy | Seizure Disorders

United States
Eisai Inc.

Completed

A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures

Epilepsy

China
Eisai Inc.

Completed

A Study to Investigate the Potential Pharmacokinetic Interaction of Perampanel With Oral Contraceptives in Healthy Female Subjects

Partial Onset Epilepsy

United Kingdom
Eisai Inc.

Completed

A Study to Demonstrate Bioequivalence Between 6 x 2 mg Tablets of Perampanel and a Single 12 mg Tablet of Perampanel in Healthy Subjects

Partial Onset Epilepsy

United Kingdom
GlaxoSmithKline

Withdrawn

GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Epilepsy

United States
Eisai Co., Ltd.

Completed

An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs)

Refractory Partial Seizures

Japan
Nova Scotia Health Authority
Nova Scotia Health Research Foundation

Unknown

Neuroimaging Predictors of Treatment Failure in Adult New-onset Epilepsy

Epilepsy | Seizures

Canada
University of Calgary
University of Alberta; University of Toronto; University of Western Ontario,... and other collaborators

Terminated

A Multicenter Study of Hippocampal Electrical Stimulation (HS, in Mesial Temporal Lobe Epilepsy (METTLE)

Temporal Lobe Epilepsy

Canada
Medical University of South Carolina

Completed

The Effect of Music Periodicity on Interictal Epileptiform Discharges

Epilepsy | Seizures | Rolandic Epilepsy | Benign Childhood Epilepsy With Centrotemporal Spikes

United States
Novartis Pharmaceuticals

Completed

Pediatric Epilepsy Study

Epilepsy

United States, Germany, Brazil, Mexico
Novartis Pharmaceuticals

Completed

Pediatric Epilepsy Study

Epilepsy | Epilepsies, Partial

United States, Germany, Brazil, Mexico
Eisai Inc.

Completed

Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy

Epilepsy, Complex Partial

United States, Estonia, Ukraine, Hungary, Lithuania
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy

Epilepsy | Epilepsy, Generalized | Seizures | Epilepsies, Partial | Epilepsy, Tonic-Clonic
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy

Epilepsy | Seizures | Epilepsies, Partial
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy

Epilepsy | Seizures
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.

Epilepsy | Seizures | Epilepsies, Partial
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy

Epilepsy | Seizures | Epilepsies, Partial
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Multicenter Trial for Adults With Partial Seizures

Epilepsy
cerbomed GmbH

Completed

Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy

Epilepsy

Germany
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients

Epilepsy | Epilepsy, Generalized | Seizures | Epilepsies, Partial
University of California, Los Angeles

Completed

Early Surgical Intervention to Treat Epilepsy (ERSET)

Epilepsy | Seizures | Epilepsy, Temporal Lobe

United States
Pfizer

Completed

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures

Seizure Disorder, Partial

United States, Canada
Scienze Neurologiche Ospedaliere

Unknown

Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis (EpIc)

Stroke | Epileptic Seizures

Italy

Search clinical trials for: Partial Onset Seizures (POS)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations